Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ARRY > SEC Filings for ARRY > Form 8-K on 20-Feb-2014All Recent SEC Filings

Show all filings for ARRAY BIOPHARMA INC

Form 8-K for ARRAY BIOPHARMA INC


20-Feb-2014

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On February 20, 2014, Array BioPharma and Oncothyreon Inc. issued a joint press release announcing the initiation of a Phase 1b trial of ONT-380 (ARRY-380) in combination with Kadcylaź (ado-trastuzumab emtansine or TDM-1) in patients with metastatic HER2+ breast cancer.

A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.   Description
   99.1       Press release announcing Initiation of Phase 1b Trial of ONT-380 in
              Combination with TDM-1 in Patients with Metastatic HER2+ Breast
              Cancer


  Add ARRY to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ARRY - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.